FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200324616> ?p ?o ?g. }

• W4200324616 endingPage "S412" @default.
• W4200324616 startingPage "S412" @default.
• W4200324616 abstract "Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is the process of administering intravenous (IV) antimicrobials outside the acute inpatient setting. Oral antimicrobials for complex infections are referred to as complex outpatient antimicrobial therapy (COpAT). OPAT/COpAT programs are expanding, as are the opportunities for clinical Infectious Diseases (ID) pharmacists (RPHs) involvement. The current state of clinical (non-dispensing) role and the functions being performed by RPHs in OPAT/COpAT is unknown. Methods To define the current state of OPAT/COpAT pharmacy practice across the United States (US), specifically the clinical functions performed by RPHs, design of RPH involved OPAT/COpAT clinics, and compare training of RPHs who practice in OPAT/COpAT to ID RPHs who do not, a survey of a possible 31 questions was emailed to the American College of Clinical Pharmacists (ACCP) Infectious Diseases Practice and Research Network (PRN) email list. Results were focused on US-based respondents. Results Eighty-seven RPHs responded with 27 practicing in OPAT/COpAT. Training background did not differ between groups. Programs with an OPAT/COpAT RPH were more likely to have a formal OPAT team compared to those without an OPAT/COpAT RPH (p &lt; 0.001). OPAT/COpAT RPHs were early in their careers, with roughly half practicing &lt; 5 years in ID, and 66.7% practicing &lt; 5 years in OPAT/COpAT. Most OPAT/COpAT RPHs (66.7%) practiced at an academic medical center with a median full time equivalent (FTE) of 1 RPH. Most (63%) utilized a collaborative practice agreement and 81.5% shared job functions with other ID RPH roles, most commonly antimicrobial stewardship. Few (28%) OPAT/COpAT programs involved a dispensing component. The average daily census was 42 patients followed by an OPAT/COpAT RPH. There was wide variability in the types of tasks ID RPH performed in OPAT/COpAT, the three most important tasks are listed in Figure 1. OPAT Pharmacists Task Ranking by Importance There was wide variability in the types of tasks ID pharmacist performed in OPAT/COpAT. The most OPAT/COpAT pharmacists responded that adjusting medications based on lab values was in their top 3 most important clinical tasks. When ranking the top three most important tasks, selecting the initial OPAT/COpAT regimen was ranked first most often, followed by review of review of OPAT appropriateness for discharge, then adjusting medications based on lab values. Conclusion This is the largest known survey of OPAT/COpAT RPHs. RPH involvement in OPAT/COpAT in the US is an emerging trend with wide variability in program structure. Tasks performed by OPAT/COpAT RPHs varied significantly; however, OPAT/COpAT RPH respondents’ functions are largely clinical in nature. Disclosures All Authors: No reported disclosures" @default.
• W4200324616 created "2021-12-31" @default.
• W4200324616 creator A5038650717 @default.
• W4200324616 creator A5052351187 @default.
• W4200324616 creator A5054056429 @default.
• W4200324616 creator A5064933186 @default.
• W4200324616 date "2021-11-01" @default.
• W4200324616 modified "2023-10-16" @default.
• W4200324616 title "619. Current State of Infectious Diseases Pharmacist OPAT/COpAT Practice in the United States" @default.
• W4200324616 doi "https://doi.org/10.1093/ofid/ofab466.817" @default.
• W4200324616 hasPublicationYear "2021" @default.
• W4200324616 type Work @default.
• W4200324616 citedByCount "0" @default.
• W4200324616 crossrefType "journal-article" @default.
• W4200324616 hasAuthorship W4200324616A5038650717 @default.
• W4200324616 hasAuthorship W4200324616A5052351187 @default.
• W4200324616 hasAuthorship W4200324616A5054056429 @default.
• W4200324616 hasAuthorship W4200324616A5064933186 @default.
• W4200324616 hasBestOaLocation W42003246161 @default.
• W4200324616 hasConcept C10446079 @default.
• W4200324616 hasConcept C104863432 @default.
• W4200324616 hasConcept C194828623 @default.
• W4200324616 hasConcept C2779457091 @default.
• W4200324616 hasConcept C2779974597 @default.
• W4200324616 hasConcept C512399662 @default.
• W4200324616 hasConcept C71924100 @default.
• W4200324616 hasConceptScore W4200324616C10446079 @default.
• W4200324616 hasConceptScore W4200324616C104863432 @default.
• W4200324616 hasConceptScore W4200324616C194828623 @default.
• W4200324616 hasConceptScore W4200324616C2779457091 @default.
• W4200324616 hasConceptScore W4200324616C2779974597 @default.
• W4200324616 hasConceptScore W4200324616C512399662 @default.
• W4200324616 hasConceptScore W4200324616C71924100 @default.
• W4200324616 hasIssue "Supplement_1" @default.
• W4200324616 hasLocation W42003246161 @default.
• W4200324616 hasLocation W42003246162 @default.
• W4200324616 hasOpenAccess W4200324616 @default.
• W4200324616 hasPrimaryLocation W42003246161 @default.
• W4200324616 hasRelatedWork W2031155718 @default.
• W4200324616 hasRelatedWork W2052892900 @default.
• W4200324616 hasRelatedWork W2325273236 @default.
• W4200324616 hasRelatedWork W2391422502 @default.
• W4200324616 hasRelatedWork W2725236363 @default.
• W4200324616 hasRelatedWork W2749406675 @default.
• W4200324616 hasRelatedWork W2848508780 @default.
• W4200324616 hasRelatedWork W2954475304 @default.
• W4200324616 hasRelatedWork W3136967969 @default.
• W4200324616 hasRelatedWork W2949077388 @default.
• W4200324616 hasVolume "8" @default.
• W4200324616 isParatext "false" @default.
• W4200324616 isRetracted "false" @default.
• W4200324616 workType "article" @default.